Myriad Genetics (MYGN) Free Cash Flow (2009 - 2026)
Myriad Genetics (MYGN) reported Free Cash Flow of -$21.1 million for Q1 2026, up 2.31% year-over-year from -$20.6 million in Q1 2025, and down 457.63% quarter-over-quarter from $5.9 million in Q4 2025.
Myriad Genetics (MYGN) Free Cash Flow (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has 18 years of Free Cash Flow data on file, last reported at -$21.1 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$21.1 million, up 2.31% year-over-year; the trailing twelve-month figure through Mar 2026 was -$13.3 million (up 44.58% YoY), and the FY2025 annual result was -$13.8 million, up 50.18% from the prior year.
- Free Cash Flow slipped to -$21.1 million in Q1 2026 per MYGN's latest filing, from $5.9 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $18.3 million in Q3 2025 and troughed at -$111.3 million in Q4 2023.
- A 5-year average of -$22.8 million and a median of -$19.7 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow sank 533.71% in 2022, then jumped 753.57% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$52.6 million in 2022, then sank by 111.6% to -$111.3 million in 2023, then jumped by 102.7% to $3.0 million in 2024, then surged by 96.67% to $5.9 million in 2025, then slumped by 457.63% to -$21.1 million in 2026.
- Business Quant data shows MYGN's Free Cash Flow at -$21.1 million in Q1 2026, $5.9 million in Q4 2025, and $18.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -42.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 816.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.09 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 257.97 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 201.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 18.03 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 491.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 122.38 Mn |
| 10 | Myriad Genetics | 424.93 Mn | 300.53 Mn | 137.60 Mn | -21.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.10 Mn |
| Mar 31, 2026 | -21.10 Mn |
| Dec 31, 2025 | 5.90 Mn |
| Dec 31, 2025 | 5.90 Mn |
| Sep 30, 2025 | 18.30 Mn |
| Sep 30, 2025 | 18.30 Mn |
| Jun 30, 2025 | -16.40 Mn |
| Jun 30, 2025 | -16.40 Mn |
| Mar 31, 2025 | -21.60 Mn |
| Mar 31, 2025 | -21.60 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | -2.80 Mn |
| Sep 30, 2024 | -2.80 Mn |
| Jun 30, 2024 | -2.60 Mn |
| Jun 30, 2024 | -2.60 Mn |
| Mar 31, 2024 | -25.30 Mn |
| Mar 31, 2024 | -25.30 Mn |
| Dec 31, 2023 | -111.30 Mn |
| Dec 31, 2023 | -111.30 Mn |